Population pharmacokinetic-pharmacodynamic-disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritis.

Author: AlmonRichard R, DuboisDebra C, JuskoWilliam J, LiuDongyang, LonHoi-Kei

Paper Details 
Original Abstract of the Article :
A population pharmacokinetic-pharmacodynamic-disease progression (PK/PD/DIS) model was developed to characterize the effects of anakinra in collagen-induced arthritic (CIA) rats and explore the role of interleukin-1β (IL-1β) in rheumatoid arthritis. The CIA rats received either vehicle, or anakinra ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/22002845

データ提供:米国国立医学図書館(NLM)

Modeling Anakinra’s Effects on Collagen-Induced Arthritis

The study of [rheumatoid arthritis] has advanced significantly with a focus on understanding the role of [IL-1β] in disease progression. This study utilizes a [population pharmacokinetic-pharmacodynamic-disease progression (PK/PD/DIS)] model to investigate the effects of [anakinra] in [collagen-induced arthritic (CIA) rats]. The authors aim to characterize the drug's [pharmacokinetic] and [pharmacodynamic] properties and assess the role of [IL-1β] in [rheumatoid arthritis].

Unveiling the Dynamics of Anakinra in Arthritis

The model developed in this study effectively captures the [pharmacokinetic] and [pharmacodynamic] profiles of [anakinra] in [CIA rats]. The authors found that [anakinra] had [modest effects] on [paw edema], suggesting a potential role in managing [rheumatoid arthritis]. This research offers a valuable tool for understanding the complex interplay between [drug effects] and [disease progression].

Navigating the Desert of Rheumatoid Arthritis Treatment

The desert of [rheumatoid arthritis] treatment is constantly evolving, with new insights into disease mechanisms and therapeutic approaches. This study contributes to this evolving landscape by providing a detailed model of [anakinra]’s effects in [CIA rats]. This research paves the way for a more precise understanding of the drug’s efficacy and potential applications in managing [rheumatoid arthritis] in humans.

Dr.Camel's Conclusion

This study utilizes a [population PK/PD/DIS] model to investigate the effects of [anakinra] in [CIA rats]. The model effectively captures the drug’s [pharmacokinetic] and [pharmacodynamic] properties, providing insights into the complex interplay between [drug effects] and [disease progression]. This research offers valuable information for developing more effective and targeted therapies for [rheumatoid arthritis] in humans.

Date :
  1. Date Completed 2012-03-20
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

22002845

DOI: Digital Object Identifier

NIHMS392751

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.